Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Background: Much controversy surrounds the association of traditional cardiovascular disease risk factors with venous thromboembolism (VTE). Methods: We performed an individual level random-effect meta-analysis including 9 prospective studies with measured baseline cardiovascular disease risk factors and validated VTE events. Definitions were harmonized across studies. Traditional cardiovascular disease risk factors were modeled categorically and continuously using restricted cubic splines. Estimates were obtained for overall VTE, provoked VTE (ie, VTE occurring in the presence of 1 or more established VTE risk factors), and unprovoked VTE, pulmonary embolism, and deep-vein thrombosis. Results: The studies included 244 865 participants with 4910 VTE events occurring during a mean follow-up of 4.7 to 19.7 years per study. Age, sex, and body mass index-adjusted hazard ratios for overall VTE were 0.98 (95% confidence interval [CI]: 0.89−1.07) for hypertension, 0.97 (95% CI: 0.88−1.08) for hyperlipidemia, 1.01 (95% CI: 0.89−1.15) for diabetes mellitus, and 1.19 (95% CI: 1.08−1.32) for current smoking. After full adjustment, these estimates were numerically similar. When modeled continuously, an inverse association was observed for systolic blood pressure (hazard ratio=0.79 [95% CI: 0.68−0.92] at systolic blood pressure 160 vs 110 mm Hg) but not for diastolic blood pressure or lipid measures with VTE. An important finding from VTE subtype analyses was that cigarette smoking was associated with provoked but not unprovoked VTE. Fully adjusted hazard ratios for the associations of current smoking with provoked and unprovoked VTE were 1.36 (95% CI: 1.22−1.52) and 1.08 (95% CI: 0.90−1.29), respectively. Conclusions: Except for the association between cigarette smoking and provoked VTE, which is potentially mediated through comorbid conditions such as cancer, the modifiable traditional cardiovascular disease risk factors are not associated with increased VTE risk. Higher systolic blood pressure showed an inverse association with VTE. # Clinical Perspective {#article-title-33}

[1]  S. Yusuf,et al.  Venous thromboembolism in association with features of the metabolic syndrome. , 2007, QJM : monthly journal of the Association of Physicians.

[2]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[3]  L. Wilhelmsen,et al.  Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men , 2008, Journal of thrombosis and haemostasis : JTH.

[4]  J. Hansen,et al.  Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study , 2008, Journal of thrombosis and haemostasis : JTH.

[5]  C. Dethlefsen,et al.  Anthropometry, Body Fat, and Venous Thromboembolism: A Danish Follow-Up Study , 2009, Circulation.

[6]  R. White,et al.  The epidemiology of venous thromboembolism. , 2003, Circulation.

[7]  Lewis H Kuller,et al.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. , 2013, JAMA.

[8]  T. Ortel,et al.  Venous thromboembolism: a public health concern. , 2010, American journal of preventive medicine.

[9]  A. Folsom,et al.  Association between cardiovascular disease risk factors and occurrence of venous thromboembolism , 2012, Thrombosis and Haemostasis.

[10]  S. Cessie,et al.  Cigarette smoking and the risk of venous thromboembolism: The Tromsø Study , 2012, Journal of thrombosis and haemostasis : JTH.

[11]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[12]  G. Jensen,et al.  Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study , 2010, Circulation.

[13]  A. Folsom,et al.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. , 2002, Archives of internal medicine.

[14]  P. Romundstad,et al.  Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2) , 2010, Haematologica.

[15]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[16]  A. Folsom,et al.  Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. , 2010, American journal of public health.

[17]  W. Buczko,et al.  Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[18]  A. Folsom,et al.  Racial and Regional Differences in Venous Thromboembolism in the United States in 3 Cohorts , 2014, Circulation.

[19]  A. Folsom,et al.  Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. , 2016, Diabetes research and clinical practice.

[20]  Douglas G. Altman,et al.  Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice , 2012, PloS one.

[21]  P. Libby,et al.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism. , 2009, The New England journal of medicine.

[22]  Hans L Hillege,et al.  Microalbuminuria and risk of venous thromboembolism. , 2009, JAMA.

[23]  Fengjuan Yao,et al.  Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis , 2013, PLoS medicine.

[24]  P. Ridker,et al.  Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)‐style diet with risks of cardiovascular disease and venous thromboembolism , 2012, Journal of thrombosis and haemostasis : JTH.

[25]  Danielle M. Enserro,et al.  Biomarkers for the prediction of venous thromboembolism in the community. , 2016, Thrombosis research.

[26]  P. Prandoni Venous thromboembolism and atherosclerosis: is there a link? , 2007, Journal of thrombosis and haemostasis : JTH.

[27]  J. Hansen,et al.  Competing Risk of Atherosclerotic Risk Factors for Arterial and Venous Thrombosis in a General Population: The Tromsø Study , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Zhiqiang Ma,et al.  Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. , 2015, Thrombosis research.

[29]  Diane Lacaille,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .

[30]  Cecilia Becattini,et al.  Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.

[31]  C. Combescure,et al.  Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. , 2016, European journal of internal medicine.

[32]  F R Rosendaal,et al.  Risk Factors for Venous Thrombotic Disease , 1999, Thrombosis and Haemostasis.